Goodwin has been assigned the vaginal mesh cases as part of federal multi-district litigation.
Thousands of women contend the New Jersey-based company used materials in its vaginal mesh products that shouldn't be permanently implanted in humans. The mesh material was designed to support deteriorated pelvic muscles and treat urinary incontinence.
The women claim the mesh degrades and shrinks, requiring replacement and causing other medical problems.
Officials with the U.S. Food and Drug Administration estimate 300,000 women had pelvic organ prolapse surgery in 2010 and mesh was used in a third of the procedures.
Bard contends the mesh was safe for its intended use and had been approved by the FDA.
In 2008, the FDA said it had received more than 1,000 complaints in three years relating to transvaginal mesh products. In 2011, more than 2,800 reports were received about vaginal mesh complications, according to the FDA.
Reach Kate White at kate.wh...@wvgazette.com or 304-348-1723.